ACADIA PHARMACEUTICALS INC (ACAD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q3 '24: 250.4M Q4 '24: 259.6M Q1 '25: 244.3M Q2 '25: 264.6M Q3 '25: 278.6M Q4 '25: 284M Q1 '26: 268.1M Q2 '26: 308M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 80M 160M 240M Q1 '22: 112.5M Q2 '22: 131.9M Q3 '22: 128.6M Q4 '22: 134.1M Q1 '23: 116.8M Q2 '23: 157.8M Q3 '23: 197.1M Q4 '23: 213.2M Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating Income Quarterly

-60M 0 60M 120M 180M Q3 '24: 31.6M Q4 '24: 153.5M Q1 '25: 19.3M Q2 '25: 32.4M Q3 '25: 35.8M Q4 '25: 17.4M Q1 '26: -4.6M Q2 '26: 37.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

0 100M 200M 300M Q3 '24: 32.8M Q4 '24: 143.7M Q1 '25: 19M Q2 '25: 26.7M Q3 '25: 71.8M Q4 '25: 273.6M Q1 '26: 3.6M Q2 '26: 31.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 10M 20M 30M Q3 '24: 18.9M Q4 '24: 21.8M Q1 '25: 20.4M Q2 '25: 20.7M Q3 '25: 21.6M Q4 '25: 26.2M Q1 '26: 24.8M Q2 '26: 28.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

0 35M 70M 105M Q2 '24: 25M Q3 '24: 63.2M Q4 '24: 40.4M Q1 '25: 20.3M Q2 '25: 64M Q3 '25: 74.3M Q1 '26: 34M Q2 '26: 100.8M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-35M 0 35M 70M 105M Q4 '22: -23.9M Q3 '24: 63.2M Q4 '24: 39.9M Q1 '25: 20.3M Q2 '25: 63.7M Q3 '25: 73.9M Q1 '26: 28.8M Q2 '26: 95.7M Q4 '22 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '24: 166.6M Q2 '24: 166.2M Q3 '24: 166.2M Q1 '25: 167.7M Q2 '25: 168.7M Q3 '25: 170.7M Q1 '26: 172.7M Q2 '26: 172.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.80 1.60 2.40 Q3 '24: 0.78 Q4 '24: 1.36 Q1 '25: 1.37 Q2 '25: 1.33 Q3 '25: 1.55 Q4 '25: 2.30 Q1 '26: 2.21 Q2 '26: 2.23 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.